StockData
Nanobiotix S.A. logo

Nanobiotix S.A. (NBTX) stock

NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$27.45−1.09 (-3.82%)

Close on Nov 17, 2026Market cap $1.33BP/E –Yield –

What Nanobiotix keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Operating margin-33.2%vs -33.2%
EBITDA margin-28.6%vs -28.6%
Pretax margin-73.5%vs -36.6%
Net margin-73.5%vs 5.34%
Free cash flow margin-104.2%vs -24.4%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on assets-27.6%vs -1.57%
Return on capital employed-25.5%vs -23.8%

How hard the assets work

Revenue per dollar of assets0.38vs 0.31
Revenue per employee€336.01Kvs €855.98K
Profit per employee-€247.02Kvs -€43.26K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by €110.89M. That is 10.1% of the €1.09B it would cost to buy the business outright.

Cash and short-term investments€110.89M
EBITDA, trailing twelve months-€9.32M
Free cash flow, trailing twelve months-€33.96M

Leverage and liquidity

Current ratio1.44vs 3.49
Quick ratio1.31vs 1.51

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

4.80
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

4 of 9 tests passed

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield-1.99%vs -1.99%
Free cash flow yield-2.82%vs -13.2%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

42
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

NBTXS&P 500
PeriodNBTXS&P 500DifferenceNBTX per yearS&P 500 per year
1 month+28.9%-4.0%+32.9 pts
3 months-34.7%-5.0%−29.7 pts
Year to date+18.7%+8.2%+10.5 pts
1 year+25.4%+11.2%+14.2 pts
3 years+348.9%+68.5%+280.4 pts+65.0%+19.0%
5 years+192.6%+67.3%+125.4 pts+24.0%+10.8%

How much it moves

Volatility, 1 year85.2%vs 65.6%
Volume against its 90-day average0.72vs 0.89

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M NBTX shares were sold short on Oct 30, 2026, down 13.4% from the previous report. At recent volumes it would take 1.4 days to buy them back. Over the last 20 sessions, 41.9% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Days of volume to buy it back1.39vs 3.54

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026170,082-13.4%122,2711.4
Oct 15, 2026196,508+33.8%158,0511.2
Sep 30, 2026146,868-16.5%141,3221.0
Sep 15, 2026175,987+17.9%125,3091.4
Aug 31, 2026149,217+12.0%203,9891.0
Aug 14, 2026133,287+34.1%133,9221.0
Jul 31, 202699,409+17.6%141,0731.0
Jul 15, 202684,555+61.0%103,8621.0
Jun 30, 202652,503-19.8%86,4641.0
Jun 15, 202665,485+95.9%64,6581.0
May 29, 202633,421-58.4%57,6361.0
May 15, 202680,248+114.6%114,5551.0

Every measure, in full

62 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Valuation ratiosIndustry

Market Cap
€1.20B
€764.28M
Enterprise Value
€1.09B
€531.82M
PS Ratio
36.95
6.73

Enterprise valuationIndustry

EV / Sales
33.55
4.06

Share statisticsIndustry

Shares Change (YoY)
1.17%
5.61%
Float
48M
79M
Shares Held by Insiders
0.00%
9.05%
Shares Held by Institutions
12.0%
33.0%

Short sellingIndustry

Short Interest
170,082
–
Short Interest Change
-13.4%
-2.55%
Days to Cover
1.39
3.54

Stock price statisticsIndustry

Price Change (1 Week)
-16.5%
-5.20%
Price Change (1 Month)
30.2%
1.00%
Price Change (3 Months)
-39.5%
-31.9%
Price Change (6 Months)
-40.6%
-19.6%
Price Change (YTD)
18.7%
-17.4%
Price Change (1 Year)
32.0%
-18.6%
Price Change (3 Years)
348.9%
-16.4%
Price Change (5 Years)
201.8%
-58.7%
Average Volume (10 Days)
169,303
–
Average Volume (20 Days)
153,935
–
Average Volume (90 Days)
149,123
–
Relative Volume
0.72
0.89
Relative Strength Index (14)
42.2
41.1
Volatility (1 Year)
85.2%
65.6%

MarginsIndustry

Operating Margin
-33.2%
-33.2%
Pretax Margin
-73.5%
-36.6%
Profit Margin
-73.5%
5.34%
EBITDA Margin
-28.6%
-28.6%
FCF Margin
-104.2%
-24.4%

Returns on capitalIndustry

Return on Assets (ROA)
-27.6%
-1.57%
Return on Capital Employed (ROCE)
-25.5%
-23.8%

Financial positionIndustry

Current Ratio
1.44
3.49
Quick Ratio
1.31
1.51
Interest Coverage
-0.71
-0.71

GrowthIndustry

Revenue Growth (3Y CAGR)
89.7%
1.61%
Revenue Growth (5Y CAGR)
67.0%
14.0%

EfficiencyIndustry

Asset Turnover
0.38
0.31
Revenue Per Employee
€336.01K
€855.98K
Profits Per Employee
-€247.02K
-€43.26K
Employee Count
97
304

Income statement (TTM)Industry

Revenue
€32.59M
€465.66M
Operating Income
-€10.82M
-€54.01M
Pretax Income
-€23.96M
-€47.40M
Net Income
-€23.96M
€157.18M
EBITDA
-€9.32M
-€42.85M
EPS (Diluted)
-0.50 EUR
-0.55 EUR

Balance sheetIndustry

Cash & Short-Term Investments
€110.89M
€199.29M
Net Cash (Debt)
€110.89M
€111.50M
Net Cash Per Share
2.29 EUR
1.53 EUR
Working Capital
€37.55M
€119.55M

Cash flow (TTM)Industry

Operating Cash Flow
-€33.42M
-€42.16M
Capital Expenditures
-€538.00K
-€2.34M
Free Cash Flow
-€33.96M
-€52.90M
FCF Per Share
-0.70 EUR
-0.48 EUR

Dividends and yieldsIndustry

Earnings Yield
-1.99%
-1.99%
FCF Yield
-2.82%
-13.2%

Taxes and interestIndustry

Interest Expense
€15.23M
€55.20M
Income Tax
€3.00K
€80.00K

Scores and fair valueIndustry

Altman Z-Score
4.80
1.08
Piotroski F-Score
4
5

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?